title: An updated review of target-specific oral anticoagulants used in stroke prevention in atrial fibrillation, venous thromboembolic disease, and acute coronary syndromes.
authors.affiliation: Department of Cardiovascular Medicine, Boston University School of Medicine, Boston, MA.
authors.forename: Christina L
authors.initials: CL
authors.lastname: Cove
authors.forename: Elaine M
authors.initials: EM
authors.lastname: Hylek
mesh_terms: D054058:Acute Coronary Syndrome / Q000150:complications* / Q000188:drug therapy; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000150:complications* / Q000188:drug therapy; D001562:Benzimidazoles / Q000627:therapeutic use; D000069604:Dabigatran; D006801:Humans; D018570:Risk Assessment; D020521:Stroke / Q000209:etiology* / Q000517:prevention & control*; D054556:Venous Thromboembolism / Q000150:complications* / Q000188:drug therapy; D014859:Warfarin / Q000627:therapeutic use; D015091:beta-Alanine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D015091:beta-Alanine; D014859:Warfarin; D000069604:Dabigatran
keywords: anticoagulants; apixaban; dabigatran; rivaroxaban; warfarin